Academic Conference
Celebrating Heer Medical's Great Success at the 7th China Pathology Annual Conference of the Pathology Branch of the Chinese Medical Association
In October 2017, the 23rd Academic Conference of the Pathology Branch of the Chinese Medical Association and the 7th China Pathology Annual Conference were held in Suzhou. Heer Medical showcased the multispectral DNA quantitative analysis system and engaged in in-depth discussions with more than 2,000 experts on the clinical applications of DNA ploidy analysis technology.
Our company participated in the 23rd Academic Conference of the Pathology Branch of the Chinese Medical Association and the 7th China Pathology Annual Conference, held grandly at the Suzhou International Expo Center from October 27 to 29, 2017. More than two thousand cytopathology experts, directors, and technical specialists from across China and internationally attended this conference.
During the event, our company's main products — the "Fully Automatic DNA Quantitative Analysis System" and the "Multispectral DNA Quantitative Analysis System" — attracted international experts to stop and observe, inquire, and learn more. The newly launched "Multispectral DNA Quantitative Analysis System" employs our proprietary multispectral analysis technology to achieve dual staining on a single slide, scanning and separating slides with combined Papanicolaou and thionine staining. Building on the high sensitivity and high specificity of the original DNA diagnostic technology, it captures full-field images and automatically screens and analyzes images for suspected positive and negative results, achieving seamless integration of DNA quantitative analysis and TBS diagnosis.
With the goals of broadening horizons, expanding thinking, and learning from best practices, Heer fully utilized the opportunity provided by this pathology annual conference to engage in active and extensive exchange and communication with experts and technical specialists from across the country, further expanding the company's reputation and influence within the industry. Our company's technicians answered every attendee's questions in detail during the equipment demonstration, and engaged in in-depth discussions with on-site clinicians, technical specialists, and numerous distributors on the clinical application and market development prospects of DNA ploidy analysis technology. The conference was also used to promote and introduce the new products and technologies that Heer Medical will focus on developing and promoting in the next phase.
